共 50 条
- [1] Long-term efficacy and safety of a repeat treatment course of rituximab in RA patients with an inadequate response to disease-modifying anti-rheumatic drugs. [J]. ARTHRITIS AND RHEUMATISM, 2006, 54 (09): : S228 - S228
- [5] Repeated treatment courses of rituximab produce sustained efficacy in rheumatoid arthritis patients with an inadequate response to disease-modifying anti-rheumatic drugs [J]. RHEUMATOLOGY, 2008, 47 : II46 - II46
- [9] The use of conventional disease-modifying anti-rheumatic drugs in established RA [J]. BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY, 2011, 25 (04): : 523 - 533
- [10] Effectiveness and Safety of Tacrolimus in Patients with Active Rheumatoid Arthritis with Inadequate Response to Disease-modifying Anti-rheumatic Drugs: The TREASURE Study [J]. JOURNAL OF RHEUMATIC DISEASES, 2019, 26 (01): : 20 - 30